Wesley Deans
Internal Medicine · West Jordan, UTNPI 1104212877
Payments from drug & device makers
Across 106 payments — averaging $13.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$554
- Medtronic$379
- Novartis$301
- Livanova USA, Inc.$127
- Bristol Myers Squibb$21
- Teva Pharmaceuticals USA, Inc.$16
- plus $43 from 3 others
What the payments were for
- Food & beverage$1,440100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $554 |
| Medtronic | 13 | $379 |
| Novartis | 37 | $301 |
| Livanova USA, Inc. | 2 | $127 |
| Bristol Myers Squibb | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| ADMA Biomanufacturing LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| EMD Serono, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,440 in reported general payments places this provider in the 75th percentile of 496 internal medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 29 | $333,297 |
| Kesimpta PenOfatumumab | 24 | $208,038 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 12 | $113,910 |
| EliquisApixaban | 80 | $89,971 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 21 | $87,278 |
| Aimovig AutoinjectorErenumab-Aooe | 49 | $36,925 |
| XcopriCenobamate | 19 | $23,745 |
| Lacosamide | 48 | $5,402 |
| RytaryCarbidopa/Levodopa | 11 | $4,763 |
| Levetiracetam | 166 | $4,483 |
| Lamotrigine | 171 | $3,852 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 171 | $3,383 |
| Oxcarbazepine | 46 | $2,599 |
| Gabapentin | 194 | $2,561 |
| Propranolol Hcl | 84 | $1,527 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in West Jordan
- Ahad SabetSalt Lake City$34.5M
- Barbara RizzardiSandy$27.8M
- Willard DereSalt Lake City$4.7M
- Joseph WoolleySaint George$3.6M
- Justin MansfieldOgden$3.1M
- Michael KillpackSandy$2M
- Cuper Martinez SantibanezWest Valley City$1M
- Joshua OaksBountiful$973K
- Brandon WebbSalt Lake City$544K
- Yong Hui AhnSlc$474K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.